[go: up one dir, main page]

GB201509935D0 - Precision therapeutics - Google Patents

Precision therapeutics

Info

Publication number
GB201509935D0
GB201509935D0 GBGB1509935.1A GB201509935A GB201509935D0 GB 201509935 D0 GB201509935 D0 GB 201509935D0 GB 201509935 A GB201509935 A GB 201509935A GB 201509935 D0 GB201509935 D0 GB 201509935D0
Authority
GB
United Kingdom
Prior art keywords
therapeutics
precision
precision therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1509935.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GLOBALACORN Ltd AND KING S COLLEGE LONDON
Original Assignee
GLOBALACORN Ltd AND KING S COLLEGE LONDON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GLOBALACORN Ltd AND KING S COLLEGE LONDON filed Critical GLOBALACORN Ltd AND KING S COLLEGE LONDON
Priority to GBGB1509935.1A priority Critical patent/GB201509935D0/en
Publication of GB201509935D0 publication Critical patent/GB201509935D0/en
Priority to PCT/GB2016/051690 priority patent/WO2016198859A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • A61K49/1812Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1509935.1A 2015-06-08 2015-06-08 Precision therapeutics Ceased GB201509935D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1509935.1A GB201509935D0 (en) 2015-06-08 2015-06-08 Precision therapeutics
PCT/GB2016/051690 WO2016198859A1 (en) 2015-06-08 2016-06-08 Precision therapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1509935.1A GB201509935D0 (en) 2015-06-08 2015-06-08 Precision therapeutics

Publications (1)

Publication Number Publication Date
GB201509935D0 true GB201509935D0 (en) 2015-07-22

Family

ID=53785142

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1509935.1A Ceased GB201509935D0 (en) 2015-06-08 2015-06-08 Precision therapeutics

Country Status (2)

Country Link
GB (1) GB201509935D0 (en)
WO (1) WO2016198859A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7408563B2 (en) * 2017-12-22 2024-01-05 フリーダム ウェイブス エッセ.エッレ.エッレ. System and method for inducing sonoporation of drugs into cancer cells
CN109265676B (en) * 2018-08-08 2021-04-09 四川大学 Folate polyethylene glycol cholesterol lipid material and application thereof
JP7534796B2 (en) * 2019-01-08 2024-08-15 ユニバーシティー オブ ジョージア リサーチ ファウンデーション, インコーポレイテッド TARGETED NANOPARTICLES AND THEIR USE IN RELATION TO FUNGAL INFECTIONS -

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096806A1 (en) * 2009-02-23 2010-08-26 Duke University Methods for loading contrast agents into a liposome
GB0920304D0 (en) * 2009-11-20 2010-01-06 Medical Res Council Novel liposome nanoparticles for tumour magnetic resonance imaging

Also Published As

Publication number Publication date
WO2016198859A1 (en) 2016-12-15

Similar Documents

Publication Publication Date Title
IL283100A (en) Glycotargeting therapeutics
IL248081A0 (en) Supramolecular combinatorial therapeutics
AU364418S (en) Dial
IL257958A (en) Glycotargeting therapeutics
AU364415S (en) Dial
AU362988S (en) Dial
GB201522309D0 (en) Use
GB201522311D0 (en) Use
GB201509935D0 (en) Precision therapeutics
GB201521085D0 (en) Use
GB201518466D0 (en) Use
GB201510077D0 (en) Use
GB201514944D0 (en) Scales
GB201509839D0 (en) One piece
GB201522573D0 (en) Cancer therapeutics
GB201503273D0 (en) Cancer therapeutics
GB201500760D0 (en) Cancer therapeutics
GB201521142D0 (en) Chalk
GB201509535D0 (en) Chalk
GB201507915D0 (en) Was I there?
AU366960S (en) Chalkboard
IL242773A0 (en) Construction set
GB201522411D0 (en) Use
GB201522443D0 (en) Use
PH32015000250S1 (en) Crayon case

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)